Repository logo
 
Publication

Acute Treatment of Isolated Posterior Cerebral Artery Occlusion: Single Center Experience

dc.contributor.authorCunha, B
dc.contributor.authorBaptista, M
dc.contributor.authorPamplona, J
dc.contributor.authorCarvalho, R
dc.contributor.authorPerry da Câmara, C
dc.contributor.authorAlves, M
dc.contributor.authorPapoila, AL
dc.contributor.authorNunes, AP
dc.contributor.authorReis, J
dc.contributor.authorFragata, I
dc.date.accessioned2023-02-10T09:21:22Z
dc.date.available2023-02-10T09:21:22Z
dc.date.issued2022
dc.description.abstractBackground and objectives: Randomized trials for mechanical thrombectomy (MT) excluded patients with ischemic strokes due to isolated posterior cerebral artery occlusion (IPCAO), and there is no evidence for best acute treatment strategy in these patients. We aimed to assess the effectiveness and safety of MT in acute IPCAO. Methods: We retrospectively analyzed consecutive patients with acute stroke due to IPCAO submitted to MT and/or intravenous thrombolysis (IVT), between 2015-2019. Effectiveness outcomes (recanalization rate, first-pass effect, NIHSS 24h improvement and 3-month Modified Ranking Scale - mRS) and safety outcomes (complications, symptomatic intracranial hemorrhage (SICH) and 3-month mortality) were described and compared between groups. Results: A total of 38 patients were included, 25 underwent MT and 13 had IVT alone. Successful and complete recanalization were achieved in 68% and 52% of MT patients, respectively. NIHSS improvement at 24h was found in 56% of MT patients versus 30.8% of patients submitted to IVT alone (OR [95% CI]=2.86 [0.69-11.82]) and excellent functional outcome at 3 months (mRS≤1) was achieved in 54.2% of MT patients versus 38.5% in the IVT group (OR [95% CI]=1.60 [0.41-6.32]). Complications occurred in 3 (12%) procedures and there were no SICH. Mortality at 3 months was 20% in the MT group and 15.4% in patients submitted to IVT alone. Conclusions: Our results reflect a real-world scenario in a single center and seem to support the recently growing literature showing that MT is a feasible and safe treatment in IPCAO, with favorable effectiveness.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationJ Stroke Cerebrovasc Dis . 2022 Feb;31(2):106239pt_PT
dc.identifier.doi10.1016/j.jstrokecerebrovasdis.2021.106239pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4388
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.subjectAcute stroke therapypt_PT
dc.subjectInterventionpt_PT
dc.subjectIntravenous thrombolysispt_PT
dc.subjectIschemic strokept_PT
dc.subjectMechanical thrombectomypt_PT
dc.subjectPosterior cerebral arterypt_PT
dc.subjectStrokept_PT
dc.subjectHSJ NRADpt_PT
dc.subjectHDE CINVpt_PT
dc.subjectHSJ UCVpt_PT
dc.titleAcute Treatment of Isolated Posterior Cerebral Artery Occlusion: Single Center Experiencept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue2pt_PT
oaire.citation.startPage106239pt_PT
oaire.citation.titleJournal of Stroke and Cerebrovascular Diseasespt_PT
oaire.citation.volume31pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
J Stroke Cerebrovasc Dis 2022_106239.pdf
Size:
770.58 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: